Press Releases and Publications > Other Information
Report of the Review Committee on
Regulation of Pharmaceutical Products in Hong Kong
Full Report
(642KB)
By Chapters
Executive Summary
Chapter 1 Introduction
Chapter 2 Existing Regulatory Regime
Chapter 3 Control of Drug Manufacturers and Enhancement to the Good Manufacturing Practices Scheme
Chapter 4 Pre-market Control of Drugs
Chapter 5 Regulation of Importers/Exporters, Wholesalers and Retailers
Chapter 6 Procurement and Supply of Pharmaceutical Products in the Public and Private Medical Sectors
Chapter 7 Post-market Control of Drugs and Pharmacovigilance
Chapter 8 Risk Communication, Education and Training
Chapter 9 Penalty Review
Chapter 10 Resources Implications and Establishment of a Dedicated Office on Drugs
Chapter 11 Summary of Recommendations
Annex A Membership and Terms of Reference of the Review Committee
Annex B Membership of the two Subcommittees
Annex C Membership and Terms of Reference of the Task Force and Expert Group
Annex D Implementation Plans
Annex E Recommendations requiring Legislative Amendments
Annex F Glossary of Terms
Annex G Chronology of Drug Incidents since March 2009
Annex H Drug Registration Certificate
Annex I Existing Organization of the Pharmaceutical Service
Annex J Proposed Organization of the Dedicated Office on Drugs
2010
|
Important notices
|
Privacy Policy
Last revision date:05/01/2010
(642KB)
|